The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study
- PMID: 12392829
- DOI: 10.1016/s0735-1097(02)02272-6
The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study
Abstract
Objectives: We sought to determine whether seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus (CMV) is an independent predictor of incident cardiovascular disease.
Background: Recent reports have suggested that infections may contribute to risk of cardiovascular disease. However, prospective studies of these associations in a free-living population are lacking.
Methods: We measured serum H. pylori IgG, C. pneumoniae IgG and IgA, and CMV IgG levels in Framingham Heart Study cohort participants. Blood samples were drawn during the 16th biennial examination cycle (1979 to 1982) from 1,187 participants free of cardiovascular disease (mean age 69 years) and stored at -20 degrees C. A pooled primary end point of myocardial infarction, atherothrombotic stroke, and coronary heart disease deaths was studied in relation to serology. Using a Cox model, hazard ratios (HR) and 95% confidence intervals (CI) were calculated, adjusting for age, gender, and established risk factors.
Results: Seropositivity to H. pylori IgG, C. pneumoniae IgG, C. pneumoniae IgA, and CMV IgG was 60%, 45%, 11%, and 69%, respectively. During 10 years of follow-up, incident cardiovascular disease occurred in 199 participants (16.8%). In age- and gender-adjusted models, H. pylori IgG (HR 1.09, 95% CI 0.81 to 1.46), C. pneumoniae IgG (HR 0.91, 95% CI 0.68 to 1.20), C. pneumoniae IgA (HR 0.65, 95% CI 0.39 to 1.07), and CMV IgG (HR 0.84, 95% CI 0.62 to 1.12) were not associated with incident cardiovascular disease. These associations were further attenuated after adjustment for risk factors including body mass index, total and high-density lipoprotein cholesterol, diabetes mellitus, smoking, and hypertension. These estimates did not change for the individual components of cardiovascular disease, and seropositivity to more than one organism did not alter these risk estimates substantially.
Conclusions: In this elderly cohort, chronic H. pylori, C. pneumoniae, and CMV infections, as evidenced by seropositivity, were not associated with increased risk for cardiovascular disease. Additional studies are needed to determine the relations of chronic infections to cardiovascular disease risk in younger persons.
Similar articles
-
Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.Circulation. 2003 Jan 21;107(2):251-7. doi: 10.1161/01.cir.0000044940.65226.1f. Circulation. 2003. PMID: 12538424
-
Helicobacter pylori, Chlamydia pneumoniae and myocardial infarction.Intern Med J. 2003 Jul;33(7):267-72. doi: 10.1046/j.1445-5994.2003.00349.x. Intern Med J. 2003. PMID: 12823670
-
Serum lipid profiles poorly correlate with Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus seropositivity in prospectively followed-up healthy children.Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):827-32. doi: 10.1161/01.ATV.0000158382.50942.6a. Epub 2005 Feb 3. Arterioscler Thromb Vasc Biol. 2005. PMID: 15692096
-
Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus: chronic infections and coronary heart disease.Pharmacotherapy. 2000 Jan;20(1):52-63. doi: 10.1592/phco.20.1.52.34659. Pharmacotherapy. 2000. PMID: 10641975 Review.
-
[Infections with Chlamydia pneumoniae, Helicobacter pylori or cytomegalovirus and atherosclerosis].Przegl Lek. 1999;56(9):584-7. Przegl Lek. 1999. PMID: 10695364 Review. Polish.
Cited by
-
Helicobacter pylori and cardiovascular risk: Only a dead Helicobacter is a good Helicobacter?Helicobacter. 2022 Dec;27(6):e12928. doi: 10.1111/hel.12928. Epub 2022 Aug 31. Helicobacter. 2022. PMID: 36046921 Free PMC article.
-
Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke.Nat Rev Neurol. 2016 Oct;12(10):594-604. doi: 10.1038/nrneurol.2016.125. Epub 2016 Sep 12. Nat Rev Neurol. 2016. PMID: 27615422 Review.
-
The effect of the treatment of Helicobacter pylori infection on the glycemic control in type 2 diabetes mellitus.Gastroenterol Hepatol Bed Bench. 2013 Winter;6(1):36-40. Gastroenterol Hepatol Bed Bench. 2013. PMID: 24834243 Free PMC article.
-
Differential effects of CMV infection on the viability of cardiac cells.Cell Death Discov. 2023 Apr 3;9(1):111. doi: 10.1038/s41420-023-01408-y. Cell Death Discov. 2023. PMID: 37012234 Free PMC article.
-
Infectious burden and carotid plaque thickness: the northern Manhattan study.Stroke. 2010 Mar;41(3):e117-22. doi: 10.1161/STROKEAHA.109.571299. Epub 2010 Jan 14. Stroke. 2010. PMID: 20075350 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous